BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12965902)

  • 21. Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes.
    Sun J; Fass DN; Hudson JA; Viss MA; Wieslander J; Homburger HA; Specks U
    J Immunol Methods; 1998 Feb; 211(1-2):111-23. PubMed ID: 9617836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indirect immunofluorescence (IIF) of normal washed peripheral blood cells to demonstrate antineutrophil cytoplasmic antibodies (ANCA).
    Paspaliaris B; Pamio M; Savige J
    J Clin Pathol; 2000 Oct; 53(10):774-7. PubMed ID: 11064672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.
    Boomsma MM; Stegeman CA; van der Leij MJ; Oost W; Hermans J; Kallenberg CG; Limburg PC; Tervaert JW
    Arthritis Rheum; 2000 Sep; 43(9):2025-33. PubMed ID: 11014352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic accuracy of antineutrophil cytoplasmic antibodies (ANCA) in predicting relapses of ANCA-associated vasculitis: systematic review and meta-analysis.
    Mehta P; Balakrishnan A; Phatak S; Pathak M; Ahmed S
    Rheumatol Int; 2023 Mar; 43(3):437-448. PubMed ID: 36040492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture's disease.
    Damoiseaux J; Vaessen M; Knapen Y; Csernok E; Stegeman CA; Van Paassen P; Tervaert JW
    Ann N Y Acad Sci; 2007 Aug; 1109():454-63. PubMed ID: 17785334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
    Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
    Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
    Radice A; Vecchi M; Bianchi MB; Sinico RA
    Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA).
    Savige J; Gillis D; Benson E; Davies D; Esnault V; Falk RJ; Hagen EC; Jayne D; Jennette JC; Paspaliaris B; Pollock W; Pusey C; Savage CO; Silvestrini R; van der Woude F; Wieslander J; Wiik A
    Am J Clin Pathol; 1999 Apr; 111(4):507-13. PubMed ID: 10191771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ANCA titres, even of IgG subclasses, and soluble CD14 fail to predict relapses in patients with ANCA-associated vasculitis.
    Nowack R; Grab I; Flores-Suarèz LF; Schnülle P; Yard B; van der Woude FJ
    Nephrol Dial Transplant; 2001 Aug; 16(8):1631-7. PubMed ID: 11477166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What do antineutrophil cytoplasmic antibodies (ANCA) tell us?
    Savige J; Pollock W; Trevisin M
    Best Pract Res Clin Rheumatol; 2005 Apr; 19(2):263-76. PubMed ID: 15857795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
    Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A
    Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of commercial and in-house ELISAs for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase.
    Pollock W; Dunster K; Rolland JM; Koh H; Savige J
    Pathology; 1999 Feb; 31(1):38-43. PubMed ID: 10212921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analytical and diagnostic accuracy of the EliA automated enzyme fluoroimmunoassay for antineutrophil cytoplasmic autoantibody detection.
    Villalta D; Tonutti E; Tampoia M; Bizzaro N; Papisch W; Tozzoli R; Stella S
    Clin Chem Lab Med; 2004; 42(10):1161-7. PubMed ID: 15552276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
    Sinclair D; Stevens JM
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
    Russell KA; Fass DN; Specks U
    Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?
    Holle JU; Hellmich B; Backes M; Gross WL; Csernok E
    Ann Rheum Dis; 2005 Dec; 64(12):1773-9. PubMed ID: 15843447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a multiplex flow cytometric immunoassay to detect PR3- and MPO-ANCA in active and treated vasculitis, and in inflammatory bowel disease (IBD).
    Trevisin M; Pollock W; Dimech W; Savige J
    J Immunol Methods; 2008 Jul; 336(2):104-12. PubMed ID: 18499121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis.
    Thompson GE; Fussner LA; Hummel AM; Schroeder DR; Silva F; Snyder MR; Langford CA; Merkel PA; Monach PA; Seo P; Spiera RF; St Clair EW; Stone JH; Specks U
    Front Immunol; 2020; 11():2053. PubMed ID: 33013868
    [No Abstract]   [Full Text] [Related]  

  • 39. Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission.
    Ohlsson S; Wieslander J; Segelmark M
    Clin Exp Immunol; 2003 Mar; 131(3):528-35. PubMed ID: 12605707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.
    Slot MC; Tervaert JW; Boomsma MM; Stegeman CA
    Arthritis Rheum; 2004 Apr; 51(2):269-73. PubMed ID: 15077271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.